PREDICTORS FOR OFF-THERAPY HBEAG SERO-REVERSION HEPATITIS AND HBEAG-NEGATIVE HEPATITIS IN HBEAG-POSITIVE PATIENTS DISCONTINUE NUC THERAPY ARE DIFFERENT

Chien-Wei Peng; Wen-Juei Jeng; Rong-Nan Chien; Yun-Fan Liaw

PREDICTORS FOR OFF-THERAPY HBEAG SERO-REVERSION HEPATITIS AND HBEAG-NEGATIVE HEPATITIS IN HBEAG-POSITIVE PATIENTS DISCONTINUE NUC THERAPY ARE DIFFERENT

Chien-Wei Peng
, Wen-Juei Jeng
, Rong-Nan Chien
, Yun-Fan Liaw

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Hepatology
Volume	74
State	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{c041aa56abdb4be4b24b28063c39f86f,

title = "PREDICTORS FOR OFF-THERAPY HBEAG SERO-REVERSION HEPATITIS AND HBEAG-NEGATIVE HEPATITIS IN HBEAG-POSITIVE PATIENTS DISCONTINUE NUC THERAPY ARE DIFFERENT",

author = "Chien-Wei Peng and Wen-Juei Jeng and Rong-Nan Chien and Yun-Fan Liaw",

year = "2021",

language = "American English",

volume = "74",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}